Page 6 - Trials Unit News Today

4 months Anti TB treatment as good as 6 months regimen in kids with non severe disease, said NEJM report

Get latest articles and stories on Health at LatestLY. A recent UCL-led international trial that explored tuberculosis (TB) treatment effectiveness in children has led to a change in the World Health Organisations global guidelines for managing the disease. Health News | Research: Treatment Length for Children with Tuberculosis Now Reduced.

Washington: A recent UCL-led international trial that explored tuberculosis (TB) treatment effectiveness in children has led to a change in the World Health Organisations global guidelines for...

The research, published in The New England Journal of Medicine, found that the treatment duration for the majority of children with drug sensitive tuberculosis can be shortened from six to four months, thereby reducing the burden on families and heal

Many infectious disease doctors that worked to create a vaccine against COVID-19 are now in the process of creating an HIV vaccine.

STUDENTS who have played a leading part in the worlds largest trials in the battle against Covid-19 have been recognised for their work by the…

A quarterly e-newsletter from the Centers for Disease Control and Prevention's (CDC) Office of Minority Health and Health Equity (OMHHE) sharing news, perspectives and progress in the science and practice of health equity.

The study, published today in The New England Journal of Medicine, found that dolutegravir-based regimens, which are already widely used to treat adults, reduced the chances of treatment failure among young people aged three to 18 by around 40% compa

A once-a-day antiretroviral medicine that is low-cost and easy for children to take is also more effective at suppressing HIV than standard treatments, according to a global trial led by researchers at UCL.

A study has found that the once-a-day dolutegravir-based regimen reduced the chances of treatment failure in those aged 3-18 by around 40%.